Archive readyExternal timestamp ready

創薬支援事業｜株式会社トランスジェニックグループ

https://transgenic-group.co.jp/business/bio/

April 25, 2026 at 06:22 AM JST•The archive page, viewer, and downloads use this saved version.

April 25, 2026 at 06:22 AM JST·transgenic-group.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

External timestamp

The evidence pack includes the third-party timestamp files.

External timestamp

External timestamp ready

Provider

DigiCert RFC3161

TSA time

April 25, 2026 at 08:45 PM JST

Saved page

創薬支援事業｜株式会社トランスジェニックグループ

Open the archived HTML with saved-time metadata attached.

Original URLhttps://transgenic-group.co.jp/business/bio/

StartedApril 25, 2026 at 06:22 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page describes the drug discovery support business of Transgenic Group Inc. The company provides gene-modified animal manufacturing using genome editing technology (CRISPR/Cas9), antibody production, and model mouse supply. It offers comprehensive support from exploratory research to clinical trials. The business comprises four segments: exploratory research, non-clinical testing with small and large animals, and clinical trials. The company handles multiple product categories including mice, proteins, and glycan-related products through several subsidiary companies.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.